Pko Investment Management Joint Stock CO Regeneron Pharmaceuticals, Inc. Transaction History
Pko Investment Management Joint Stock CO
- $1.17 Trillion
- Q3 2025
A detailed history of Pko Investment Management Joint Stock CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 11,200 shares of REGN stock, worth $7.77 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
11,200
Previous 18,800
40.43%
Holding current value
$7.77 Million
Previous $9.87 Billion
36.2%
% of portfolio
0.54%
Previous 1.06%
Shares
15 transactions
Others Institutions Holding REGN
# of Institutions
1,465Shares Held
85.5MCall Options Held
2.16MPut Options Held
1.65M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...